The use of intravenous thrombolytics in acute ischemic stroke management: a scoping review from 2008 till 2021 in the Arab world in the Middle East and North Africa
Objective The aim of this review was to assess and analyze the research output on
intravenous thrombolysis in acute ischemic stroke in the Arab world in the Middle East and …
intravenous thrombolysis in acute ischemic stroke in the Arab world in the Middle East and …
Health outcomes after acute ischemic stroke: retrospective and survival analysis from Oman
AM Al Alawi, I Al Busaidi, E Al Shibli… - Annals of Saudi …, 2022 - annsaudimed.net
BACKGROUND: Stroke mortality and related functional disability have been declining over
the last two decades, but stroke continues to represent the second leading cause of …
the last two decades, but stroke continues to represent the second leading cause of …
[HTML][HTML] Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial
MG Zeinhom, MFE Khalil, IFM Kamel, AM Kohail… - Scientific Reports, 2024 - nature.com
Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only
approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third …
approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third …
Endovascular thrombectomy for acute ischemic stroke in Saudi Arabia: A single-center experience
H Alhazmi, OK Ameen, Z Almalki, A Alanazi… - Journal of Stroke and …, 2024 - Elsevier
Purpose This study aimed to investigate the outcomes of endovascular thrombectomy-
treated patients in King Fahad Medical City, Riyadh, Saudi Arabia. Methods A retrospective …
treated patients in King Fahad Medical City, Riyadh, Saudi Arabia. Methods A retrospective …